Benefit or risk of aspirin treatment of giant cell arteritis: comment on the article by Weyand et al - Reply

被引:0
|
作者
Weyand, CM [1 ]
Goronzy, JJ [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 11期
关键词
D O I
10.1002/art.10523
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3113 / 3114
页数:2
相关论文
共 50 条
  • [31] Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al
    Spiera, RF
    Kupersmith, M
    Paget, S
    Spiera, H
    ARTHRITIS AND RHEUMATISM, 2003, 48 (04): : 1159 - 1160
  • [32] Reply to: Superb microvascular imaging in giant cell arteritis by Conticini et al.
    SAKELLARIOU, G.
    GIOVANNINI, I.
    GRIGNASCHI, S.
    ZABOTTI, A.
    IAGNOCCO, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (04) : 862 - 862
  • [33] Probable osteosarcoma risk after prolonged teriparatide treatment: comment on the article by Saag et al Reply
    Saag, Kenneth G.
    Krohn, Kelly
    Warner, Margaret R.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (06): : 1837 - 1838
  • [34] Aspirin as adjunctive treatment for giant cell arteritis (Review)
    Mollan, Susan P.
    Sharrack, Noor
    Burdon, Mike A.
    Denniston, Alastair K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [35] Predictors of positive temporal artery biopsy in patients with giant cell arteritis and polymyalgia rheumatica (comment on the article by Mari et al.)
    Gonzalez-Gay, Miguel A.
    Miranda-Filloy, Jose A.
    Llorca, Javier
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (01) : 51 - 51
  • [36] Comment to: "Ahuja AS et al: Paracentral Acute Middle Maculopathy as a Manifestation of Giant Cell Arteritis"
    Pellegrini, Francesco
    Interlandi, Emanuela
    Pichi, Francesco
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2022, 42 (02) : E533 - E533
  • [37] Reply:: The right place of 18FDG PET for the diagnosis of giant cell arteritis -: A response to the article of Brodmann et al.
    Brodmann, M
    Pilger, E
    RHEUMATOLOGY, 2004, 43 (05) : 676 - 676
  • [38] Comment on: British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: reply
    Mackie, Sarah
    RHEUMATOLOGY, 2020, 59 (12) : E160 - E160
  • [39] The 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis and Takayasu arteritis: comment on the articles by Ponte et al and Grayson et al
    Betrains, Albrecht
    Moreel, Lien
    Blockmans, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 (06) : 1074 - 1074
  • [40] Comment on: Statin therapy does not seem to benefit giant cell arteritis
    Pieringer, Herwig
    Blesenbach, Georg
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2008, 38 (01) : 63 - 64